Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Chemotherapy. University Hospital Groningen, Groningen, Netherlands

Survival: 7.4 months
Toxicity Grade: 5
Treatments: Chemotherapy
Drugs: Taxotere
Country: Netherlands
City/State/Province: Groningen
Hospital: University Hospital Groningen
Journal: Link
Date: 1/2005

Patients: This Phase II study involved 108 patients. The patients were divided into two groups. 56 patients were assigned to Group A. The median age of Group A was 59, and twelve were women. 42 patients had Stage IV NSCLC, and 14 had Stage IIIb. All patients had been given previous chemotherapy, and 26 had been given previous radiotherapy.

Treatment: The treatment for patients in Group A consisted of one chemotherapeutic drug: docetaxel.

Toxicity: One patient died from the toxicity of treatment. Grade 1-4 hematologic toxicities included: granulocytopenia and leucopenia. Grade 1-3 non-hematologic toxicities included: diarrhea and vulnerability to infections.

Results: The median survival for Group A was 7.4 months (32 weeks).

Support: The authors acknowledged Aventis for its support for this study. Aventis manufactures and/or markets docetaxel.

Correspondence: H. J. M. Groen, MD

E-mail to a Friend Email Physician More Information